Hanall Biopharma Co., Ltd. (KRX:009420)

South Korea flag South Korea · Delayed Price · Currency is KRW
24,750
-200 (-0.80%)
Last updated: Jun 27, 2025
-20.29%
Market Cap 1.30T
Revenue (ttm) 141.00B
Net Income (ttm) -1.69B
Shares Out 50.74M
EPS (ttm) -33.58
PE Ratio n/a
Forward PE 137.69
Dividend n/a
Ex-Dividend Date n/a
Volume 29,681
Average Volume 197,534
Open 24,950
Previous Close 24,950
Day's Range 24,700 - 25,100
52-Week Range 24,200 - 52,000
Beta 0.83
RSI 39.32
Earnings Date Aug 14, 2025

About Hanall Biopharma

Hanall Biopharma Co., Ltd., a pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally. The company offers prescription drugs and over-the-counter products for the treatment of diarrhea, prostatic hyperplasia, androgenetic alopecia, chronic renal failure, hypoparathyroidism, vitamin D-resistant rickets, osteomalacia, osteoporosis, prostate cancer, toxic liver disease, chronic hepatitis, liver cirrhosis, male pattern baldness, functional dyspepsia, diabetes, bacterial infections, peripheral vascul... [Read more]

Sector Healthcare
Founded 1973
Employees 304
Stock Exchange Korea Stock Exchange
Ticker Symbol 009420
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.